We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+9.08%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$13.4B
AUM Growth
+$76.4M
(+0.57%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-11.62%
Top 10 Holdings %
Top 10 Hldgs %
13.41%
Holding
876
New
81
Increased
315
Reduced
337
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$75.8M |
| 2 |
CME Group
CME
|
+$53.8M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$51.7M |
| 4 |
WDR
Waddell & Reed Financial, Inc.
WDR
|
+$47M |
| 5 |
Ross Stores
ROST
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$98.5M |
| 2 |
Chevron
CVX
|
+$78.9M |
| 3 |
Costco
COST
|
+$74.9M |
| 4 |
ExxonMobil
XOM
|
+$66.8M |
| 5 |
Cisco
CSCO
|
+$60M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.86% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.57% |
| 4 | Consumer Discretionary | 9.5% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
301
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.14M | 0.05% |
53,691
+1,056
| +2% | +$127K |
|
|
VIAB
302
DELISTED
Viacom Inc. Class B
VIAB
| $7.13M | 0.05% |
81,638
-3,865
| -5% | -$319K |
|
303
Grupo Cibest SA
CIB
$21.1B
| $7.1M | 0.05% |
145,166
+5,500
| +4% | +$292K |
|
|
TWX
304
DELISTED
Time Warner Inc
TWX
| $7.06M | 0.05% |
105,612
+30,723
| +41% | +$1.99M |
|
305
Newmont
NEM
$119B
| $7.06M | 0.05% |
306,449
-49,350
| -14% | -$1.27M |
|
306
Synopsys
SNPS
$79.7B
| $6.99M | 0.05% |
172,239
+50,902
| +42% | +$1.91M |
|
|
AYR
307
DELISTED
Aircastle Ltd
AYR
| $6.94M | 0.05% |
362,369
+40,040
| +12% | +$742K |
|
308
Timken Company
TKR
$9.03B
| $6.9M | 0.05% |
175,002
+7,837
| +5% | +$306K |
|
309
Ecolab
ECL
$79.9B
| $6.9M | 0.05% |
66,147
-136,179
| -67% | -$14.2M |
|
310
Everest Group
EG
$14.4B
| $6.81M | 0.05% |
43,690
+2,432
| +6% | +$371K |
|
311
Manhattan Associates
MANH
$11.4B
| $6.76M | 0.05% |
230,348
+3,772
| +2% | +$104K |
|
312
Columbia Sportswear
COLM
$2.94B
| $6.63M | 0.05% |
+168,274
| New | +$5.67M |
|
|
CTCM
313
DELISTED
CTC MEDIA INC COM STK
CTCM
| $6.61M | 0.05% |
475,474
+442,212
| +1,329% | +$5.47M |
|
314
Waste Management
WM
$91B
| $6.6M | 0.05% |
147,073
-56,732
| -28% | -$2.48M |
|
|
NPSP
315
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $6.57M | 0.05% |
216,312
+75,387
| +53% | +$2.08M |
|
316
Safety Insurance
SAFT
$1.52B
| $6.54M | 0.05% |
116,077
-20,585
| -15% | -$1.13M |
|
317
EPR Properties
EPR
$4.77B
| $6.52M | 0.05% |
132,592
-53,980
| -29% | -$2.7M |
|
318
DTE Energy
DTE
$29.1B
| $6.52M | 0.05% |
115,332
+31,337
| +37% | +$1.8M |
|
319
Starbucks
SBUX
$120B
| $6.46M | 0.05% |
164,886
-86,864
| -35% | -$3.44M |
|
320
Telefônica Brasil
VIV
$19.2B
| $6.46M | 0.05% |
336,371
+122,131
| +57% | +$2.48M |
|
321
Enterprise Products Partners
EPD
$81.7B
| $6.38M | 0.05% |
192,356
-820
| -0.4% | -$25.5K |
|
322
Truist Financial
TFC
$64B
| $6.37M | 0.05% |
170,737
+30,443
| +22% | +$1.05M |
|
323
EnerSys
ENS
$6.99B
| $6.33M | 0.05% |
90,362
+1,925
| +2% | +$129K |
|
324
Alnylam Pharmaceuticals
ALNY
$29.3B
| $6.25M | 0.05% |
97,222
+22,904
| +31% | +$1.37M |
|
|
K
325
DELISTED
Kellanova
K
| $6.22M | 0.05% |
108,500
+20,584
| +23% | +$1.19M |
|
Similar funds
BNP Paribas Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Asset Management held 876 positions worth $13.4B, up 0.57% from $13.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Asset Management withdrew a net $1.55B in Q4 2013, closing 55 positions and reducing 337 holdings. Its most notable exit was Baidu, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Asset Management opened a new position in Waddell & Reed Financial, Inc. worth $50M.
- BNP Paribas Asset Management's largest Q4 2013 buy was Waddell & Reed Financial, Inc.: 768,432 shares worth $50M.
- BNP Paribas Asset Management added most to Gilead Sciences in Q4 2013, an estimated $75.8M increase.
- BNP Paribas Asset Management's biggest Q4 2013 reduction was eBay, cutting an estimated $98.5M.
- BNP Paribas Asset Management fully exited Baidu in Q4 2013, selling an estimated $23.9M.
- BNP Paribas Asset Management's ten largest holdings make up 13% of its $13.4B portfolio in Q4 2013.
- BNP Paribas Asset Management opened 81 new positions and closed 55 in Q4 2013.
- BNP Paribas Asset Management's portfolio value rose 0.57% quarter-over-quarter to $13.4B.
Based on BNP Paribas Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.